Current Edition

Upcoming Events

Advertisement

Uncategorised

Compact solvent recycler improves HPLC sustainability.

Biotech Fluidics announce the SmartSaver solvent recycling unit - designed to recover up to 90% of your mobile phase by redirection of the pure solven...
Continue Reading →
news

Bristol Myers finally wins FDA approval for cancer cell therapy

Dive Brief: The Food and Drug Administration on Friday approved Breyanzi, a cancer cell therapy from Bristol Myers Squibb, for the treatment of late-stage lymphoma...
Continue Reading →
Uncategorised

Arrowhead shares soar on liver disease data from four patients

Shares in Arrowhead Pharmaceuticals rose by nearly 50% Wednesday after the California-based biotech said its drug for a rare liver disease reduced levels of a mutant ...
Continue Reading →
Uncategorised

Product characterization: Reveal your molecule earlier, faster, and with accuracy

Product characterization can be challenging throughout drug development because it requires advanced technologies and specialized expertise. Thus, it is vital to star...
Continue Reading →
news

Former FDA chief Gottlieb predicts Trump-pitched pricing model easy to game

As President Donald Trump's International Pricing Index slogs through the regulatory process, former Food and Drug Administration head Scott Gottlieb predicted Monday...
Continue Reading →
news

With new report, ICER puts itself at center of drug pricing storm

Pharmaceutical companies often preach value. Yet, for seven top-selling drugs, prices went up in 2017 and 2018 despite limited new evidence showing patients receiving...
Continue Reading →
news

MilliporeSigma Acquires FloDesign Sonics for Acoustic Technology for Cell Therapy

MilliporeSigma announced it has acquired FloDesign Sonics, a Wilbraham, MA-based acoustic cell processing platform developer for the industrialization of cell and gen...
Continue Reading →
news

Gene therapy biotechs caught in manufacturing crunch

Rapidly progressing gene therapy development could push more biotechs to invest in their own manufacturing capabilities over outsourcing to contract services companie...
Continue Reading →
news

Treatment of pain and inflammation with Tetra Bio-Pharma’s CAUMZ kit

CAUMZ is a non-opioid alternative in Phase 3 development for the treatment of pain and inflammation, and Tetra are one step closer to bringing the kit to market. CAUM...
Continue Reading →
news

Aridis Pharmaceuticals Appoints Infectious Disease Expert Paul Mendelman, MD as Interim Chief Medical Officer

Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-thre...
Continue Reading →